News Brief: New AD Drug Candidate Gets to First BACE
Privately owned CoMentis Inc. announced yesterday that...
6397 RESULTS
Sort By:
Privately owned CoMentis Inc. announced yesterday that...
Since mutations in the PINK1 and DJ-1 genes were found to cause autosomal recessive forms of Parkinson disease...
Alzheimer and heart disease share a common cast of villains...
Feeling stressed? If unchecked, the pressures of modern life may...
After a Phase 2 trial of the AD experimental immunotherapy AN1792 ended prematurely...
Bright young stars, listen up...
Washington: Alzhemed Non-story Yields Spotlight to Phase 2 Treatments Washington: Shaking Up AD Treatment with Ketone Bodies Washington: Site-to-Site Differences Delay Result of Alzhemed Trial Washington: γ-secretase Inhibitor Survived Phase 2, Moving to
For most people in AD research, a conference is the best place to...
At the second Alzheimer’s Association International Conference on Prevention...
To borrow a Twainism, news about the death of γ-secretase inhibitors proves to have been exaggerated...
A novel therapeutic approach captured some attention...
Physical and psychological stress can have long-lasting effects on the brain and even...
It is widely recognized that chronic stress—be it psychological or physical—is bad for one’s health. Yet...
Results from a mouse model of chronic neuroinflammation suggest that...
The apolipoprotein E4 allele (ApoE4) is the most prominent genetic risk factor for late-onset Alzheimer disease (LOAD), but it is not the whole story...
No filters selected